Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Experimed
ISSN 2667-5846 · Istanbul University Press
Experimed: CAS Zone 4 · Medicine (2026 Xinrui edition); diamond open access (no APC); no APC; median 119 days to acceptance (67 articles, last 24 months); 34 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Experimed is published by Istanbul University Press and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are MicroRNA in disease regulation, Multiple Sclerosis Research Studies and Alzheimer's disease research and treatments, together about 20% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology9%
- Multiple Sclerosis Research StudiesMedicine6%
- Alzheimer's disease research and treatmentsMedicine5%
- Genomics, phytochemicals, and oxidative stressBiochemistry, Genetics and Molecular Biology5%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology5%
- T-cell and B-cell ImmunologyImmunology and Microbiology4%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.14LetPub ·
- SNIP 2026-06
- 0.13LetPub ·
- h-index
- 6OpenAlex ·
- i10-index
- 1OpenAlex ·
- 2-year mean citedness
- 0.21OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 256 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 0 |
| 2025 | 34 | 34 | 6 |
| 2024 | 29 | 29 | 12 |
| 2023 | 38 | 38 | 37 |
| 2022 | 38 | 38 | 41 |
| 2021 | 29 | 29 | 49 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
119 daysMedian, submission to acceptance · P25–P75 78 days – 146 days
- Acceptance to online
- median 44 days (67 articles)
- Submission to online
- median 169 days
- Sample
- 67 articles with submission and acceptance dates (68 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Istanbul University Press
- ISSN
- 2667-5846
- Official links
FAQ
Frequently asked questions about Experimed
What CAS zone is Experimed in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Experimed?
Based on the dates recorded on 67 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 78–146 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Experimed?
According to LetPub and DOAJ records, Experimed is indexed in ESCI, Scopus and DOAJ.
Is Experimed open access, and what is the APC?
Experimed is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .